1. Carl Zeiss Meditec

    0 Comments Leave a Comment

    16-30 of 1597 « 1 2 3 4 5 ... 105 106 107 »
    1. Mentioned In 1597 Articles

    2. The relationship between age, axial length and retinal nerve fiber layer thickness in the normal elderly population in Taiwan: The Chiayi eye study in Taiwan

      The relationship between age, axial length and retinal nerve fiber layer thickness in the normal elderly population in Taiwan: The Chiayi eye study in Taiwan
      ...oborated the data from Alasil et al. concerning the Asian population, despite using a different SD-OCT model (Zeiss, Stratus OCT 3000 vs. Spectralis SD-OCT). In our data, the RNFL was thickest in the inferotemporal segme...
      Read Full Article
    3. Optical coherence tomography angiography in pseudophakic cystoid macular oedema compared to diabetic macular oedema: qualitative and quantitative evaluation of retinal vasculature

      Optical coherence tomography angiography in pseudophakic cystoid macular oedema compared to diabetic macular oedema: qualitative and quantitative evaluation of retinal vasculature
      ... ophthalmological examination at baseline, including OCT-A scans of the macula through AngioPlex CIRRUS-5000 (Carl Zeiss Meditec, Dublin, USA). Patients with PCMO and DMO were re-evaluated after the pharmacological resol...
      Read Full Article
    4. Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy

      Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy
      ...a consultant for Roche. Ursula Schmidt-Erfurth is a consultant for Novartis, Genentech, Bayer, Boehringer and Carl Zeiss Meditec....
      Read Full Article
    5. Record Revenue and Earnings: ZEISS Continues Growth Trajectory Investments and innovations lead to best results in the company's more than 170-year history

      Record Revenue and Earnings: ZEISS Continues Growth Trajectory Investments and innovations lead to best results in the company's more than 170-year history
      ...o the most successful fiscal year in the history of ZEISS," said Prof. Dr. Michael Kaschke, President CEO of Carl Zeiss AG, at the annual press conference in Stuttgart. "This development was not and is not just a matter...
      Read Full Article
    6. 16-30 of 1597 « 1 2 3 4 5 ... 105 106 107 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Carl Zeiss Meditec

    Carl Zeiss Meditec

    Carl Zeiss Meditec.  Ophthalmology Systems.  Carl Zeiss Meditec is an integrated medical technology company with two main areas of business activity.  In the field of ophthalmology we offer complete solutions for treating the four main eye ailments: vision defects (refraction), cataract, glaucoma and retinal disorders. Our products support doctors and patients to diagnose and treat these ailments efficiently and precisely, thus giving both of them clear benefits, not least by offering them a comprehensive disease management solution. The acquisition of Carl Zeiss Surgical has strengthened our leading market and competitive position for devices and systems in ophthalmic surgery.  Furthermore, we have secured an outstanding starting position in the growth market of neuro/ENT surgery. As the world‘s leading provider of surgical microscopes and visualisation solutions for these treatments, we will further expand our footprint in this area through organic growth and strategic expansion into adjacent market segments. In doing so, we want to develop into a solution provider in this area as well.  Carl Zeiss Meditec's medical technology portfolio is rounded off by innovative and promising future technologies such as intraoperative radiation therapy, which allows the targeted treatment of breast cancer and brain cancer during the operation stage itself.

  3. Quotes about Carl Zeiss Meditec

    1. I have come to rely on the Carl Zeiss Meditec brand for consistent and reliable technologies that are at the forefront of innovation and patient care.
      Ike K. Ahmed in Carl Zeiss Meditec Introduces New Suite of Ophthalmic Innovations
    2. Mr Taylor has been instrumental in making Meditec one of the leading companies in the field of ophthalmology in the past few years. My sincere thanks are due to him for his effort and dedication. I am pleased that Mr Taylor will continue to support us in the role of independent consultant and that we will be able to draw on his experience in future. Furthermore, I am convinced that we are ideally set with our current team to accelerate the proposed realisation of growth potential of Carl Zeiss Meditec.
      Michael Kaschke in Carl Zeiss Meditec reorganises management of its strategic business units
    3. Carl Zeiss Meditec received the highest overall Frost & Sullivan Competitive Metrics Score in the recently completed Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics Markets.
      In Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications